期刊文献+

加味关节康对佐剂性关节炎大鼠免疫性炎症的影响 被引量:4

原文传递
导出
摘要 目的:探讨加味关节康对佐剂性关节炎大鼠免疫性炎症的影响。方法:53只大鼠随机分为4组:正常组、模型组、加味关节康剂治疗组及雷公藤多甙片组,除正常组外其余大鼠制备佐剂性关节炎模型。治疗组分别用加味关节康、雷公藤多甙片ig;于药后1,2,3周测大鼠左后足趾肿胀度及关节炎指数评分。用药后3周测定血清白介素(IL)-4、8、10、12,肿瘤坏死因子(TNF)-α和干扰素(IFN-γ)水平,观察大鼠滑膜组织病理形态学变化。结果:用药后治疗组关节肿胀度及关节炎指数均小于模型组(P<0.05,P<0.01);用药3周后各治疗组血清TNF-α、IFN-γ、IL-8、IL-12水平均低于模型组(P<0.01);IL-4、IL-10水平均高于模型组(P<0.05);各治疗组与模型组比较滑膜组织增生程度明显减轻,炎症细胞浸润程度稍减轻。结论:加味关节康治疗可明显下调佐剂性关节炎大鼠相关致炎性细胞因子TNF-α、IFN-γ、IL-8、IL-12水平,并上调抗炎性细胞因子IL-4、IL-10的水平,可减轻滑膜增生程度,改善关节肿胀,疗效肯定。
机构地区 解放军第
出处 《中国实验方剂学杂志》 CAS 北大核心 2010年第3期77-79,共3页 Chinese Journal of Experimental Traditional Medical Formulae
基金 吉林省科技厅中医药研发基金(20060920)
  • 相关文献

参考文献5

  • 1陈柏松,徐玉东,钟淑琦,马彦文,马月秋.大鼠佐剂性关节炎模型的建立与评价[J].哈尔滨医科大学学报,2005,39(6):489-491. 被引量:50
  • 2Elewaut D, Keyser FD, Wever ND, et al. A comparative phenotypical analysis of rheumatoid nodules and rheumatoid synovium with special refernce to adhesion molecules and activation markers[J]. Ann Rheum Dis, 1998, 57(8): 480.
  • 3Kanik KS, Hagiwara E, Yarbom CH, et al. Distinct patterns of cytokine Secretion characterize new onset synovitis versus chornic rheumatoid arthritis[ J]. J R heumatol,1998, 25(1) :16.
  • 4Racke MK, Bonomo A. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease [J]. JExpMed, 1994, 180(8): 1961.
  • 5Simon AK, Seipelt E, Seiper J. Divergent T-cell Cytokine pattenrs in inflammatory arthritis[J]. Porc Natl Acad Sci USA, 1994, 91(7): 8562.

二级参考文献9

  • 1Lu S,Holmdahl R.Different therapeutic and bystander effects by intranasal administration of homologous type II and type IX collagens on the collagen-induced arthritis and pristane-induced arthritis in rats[J].Clin Immunol,1999,90(1):119-127.
  • 2Yoshino S,Sasatomi E,Ohsawa M.Bacterial lipopolysaccharide acts as an adjuvant to induce autoimmune arthritis in mice[J].Immunology,2000,99(4):607-614.
  • 3Bendele A.Animal models of rheumatoid arthritis[J].J Musculoskelet Neuronal Interact,2001,1(4):377-385.
  • 4Poole AR,Ionescu M,Fitzcharles MA,et al.The assessment of cartilage degradation in vivo:development of an immunoassay for the measurement in body fluids of type II collagen cleaved by collagenases[J].J Immunol Methods,2004,294(1-2):145-153.
  • 5Hyllested JL,Veje K,Ostergaard K.Histochemical studies of the extracellular matrix of human articular cartilage--a review[J].Osteoarthritis Cartilage,2002,10(5):333-343.
  • 6Jorgensen C,Gedon E,Jaquet C,et al.Gastric administration of recombinant 65 kDa heat shock protein delays the severity of type II collagen induced arthritis in mice[J].J Rheumatol,1998,25(4):763-767.
  • 7Staines NA,Harper N,Ward FJ,et al.Arthritis:animal models of oral tolerance[J].Ann N Y Acad Sci,1996,778(13):297-305.
  • 8Wernhoff P,Olofsson P,Holmdahl R.The genetic control of rheumatoid factor production in a rat model of rheumatoid arthritis[J].Arthritis Rheum,2003,48(12):3584-3596.
  • 9Revesz L,Blum E,Di Padova FE,et al.Novel p38 inhibitors with potent oral efficacy in several models of rheumatoid arthritis[J].Bioorg Med Chem Lett,2004,14(13):3595-3599.

共引文献49

同被引文献45

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部